Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mus musculus

ABSTRACT: RNA-seq data of si-Snai1, si-Snai2, si-Snai1/2 and si-Scrambled treated mouse primary myoblasts

PROVIDER: PRJNA167512 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR501033.fastq.gz	Fastqsanger.gz
	SRR501034.fastq.gz	Fastqsanger.gz
	SRR501035.fastq.gz	Fastqsanger.gz
	SRR501036.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis

Project description:This SuperSeries is composed of the following subset Series: GSE24811: Time Series of Mouse skeletal muscle cell differentiation GSE24852: ChIP-Seq of MyoD, Myf5, Snai1, HDAC1, HDAC2, E47 and empty vector controls in mouse skeletal myoblasts or myotubes GSE38236: RNA-Seq of si-Snai1, si-Snai2, si-Snai1/2 and si-Scrambled treated myoblasts Refer to individual Series

2012-07-04 | E-GEOD-24904 | biostudies-arrayexpress

Identification of differentially expressed lncRNAs and coding mRNAs in SNAI1/2 overexpression cell line

Project description:The oncogene SNAI2 is known to be a master transcription factor that regulates a broad range of cellular processes, including epithelial-mesenchymal transition (EMT). As a transcription factor, there is no doubt that SNAI1/2 could directly regulate the expression of thousands of genes, including lncRNAs. In this study, we took SNAI1/2 as a breakthrough point to screen and identify lncRNAs regulated by SNAI2 in GC. Our data showed that overexpression of SNAI2 caused a 1.5-fold change in the expression of about 654 lncRNAs (|Log2FC| >0.5), and a 2-fold change in the expression of about 123 lncRNAs (|Log2FC| >1).

2021-10-01 | GSE161551 | GEO

A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.

Project description:The propensity of cancer cells to transition between epithelial and mesenchymal phenotypic states is considered to be critical in metastatic processes, cancer progression, and treatment resistance. To investigate a transient epithelial-mesenchymal transition (EMT) in prostate adenocarcinoma, LNCaP cells with inducible and reversible expression of SNAI1 or SNAI2 were generated. Cells were treated with doxycycline to induce a SNAI1- or SNAI2-mediated EMT for 5 days and then subsequently removed for 3, 5, and 20 days to allow for MET. LNCaP-iGFP cells were also generated for control purposes and were subjected to the same treatment regime.

2018-09-11 | GSE80042 | GEO

Characterisation of the NRF2-mediated anti-oxidant gene battery by transcriptional profiling

Project description:Transcriptional profiling in HACAT cells using a whole human genome array HACAT cells treated with si RNA against Keap 1 or a scrambled si RNA sequence (Scram) vs HACAT cells mock transfected with lipofectamine (reference control)

2009-08-30 | GSE17011 | GEO

BRG1-dependent regulation of Wnt signaling pathway during skeletal muscle differentiation

Project description:RNA-seq analysis for C2C12 myoblasts knocked down for either only-BRG1 or only-BRM or both BRG1 and BRM. Cells were treated with an siRNA SMARTpools of four oligos each targeting either BRG1 (siGENOME mouse Smarca4 pool #M-041135-01-0020) or BRM (siGENOME mouse Smarca2 pool #M-056591-00-0020) or both. Control samples were treated with non-targeting scrambled oligos (siRNA SMARTpool ON-TARGETplus scrambled non-targeting pool # D-001810-10-20). siRNA pools were purchased from Dharmacon, Horizon Discovery Ltd., USA.

2023-06-24 | GSE196283 | GEO

RNA-sequencing of undifferentiated and differentiated mouse skeletal muscle cells following the depletion of SETD2

Project description:undifferentiated mouse skeletal muscle cells (myoblasts) and differentiated mouse skeletal muscle cells (myotubes) were subjected to treatment with siRNAs targeting SETD2 or a non-targeting siRNA (si-Ctrl). Differential gene expression analysis and splicing analysis was performed on the resulting data.

2022-06-03 | GSE199256 | GEO

Mus musculus

Project description:Aging primary myoblasts

| PRJNA84703 | ENA

Mus musculus

Project description:Expression data from Rspo1-null differentiating primary myoblasts

| PRJNA327823 | ENA

Mus musculus

Project description:Expression data from primary mouse hepatocytes treated with Diclofenac

| PRJNA236047 | ENA

Mus musculus

Project description:Expression data from primary myoblasts with active Beta-catenin